Amersham Confirms Takeover Feeler

NEW YORK, Oct. 8 (GenomeWeb News) – London-based Amersham today announced that it has received a possible takeover bid.

In a short written statement, Amersham, the diagnostics and healthcare giant, said it has received an approach from an unnamed party that “may or may not lead to an offer for the company as a whole.”

The short statement , available on the company website, said “no agreement has been reached and a further announcement will be made as appropriate.”

The statement was released in response to a sharp rise in its share prices today.

Published reports speculated that the buyer could be companies like Johnson & Johnson or Roche Holding.

The 10,000-employee company has a market capitalization of $7.5 billion.